Walter Moos

Dr. Walter Moos, with a PhD in Chemistry from UC Berkeley and an AB in Honors Chemistry from Harvard University, is a prominent figure in the biotechnology and pharmaceutical industries.

As the Managing Director and Co-Founder at Pandect Bioventures, Dr. Moos is known for his leadership in developing innovative ecosystems within organizations.

With a rich history in various leadership roles, including Chairman emeritus at ShangPharma Innovation and President of SRI Biosciences, Dr. Moos has contributed significantly to R&D across all phases, from early-stage research to market successes in pharmaceutical products.

Having served on numerous business and scientific boards, Dr. Moos has a vast network and experience collaborating with VCs, foundations, government agencies, big pharma, and other key stakeholders in the industry.

His academic involvement as an adjunct Professor of Pharmaceutical Chemistry at UCSF and his positions in several major universities reflect his passion for education and research.

Dr. Moos's portfolio includes over 175 patents and publications, co-authored books, and co-founding scientific journals, showcasing his immense contributions to the field.

Throughout his career, Dr. Moos has excelled in roles such as Chairman/CEO of MitoKor, a VP at Chiron and Warner-Lambert/Parke-Davis, illustrating his versatility and expertise across different organizations in the pharmaceutical sector.